Company intelligence / Profile preview

Jackson Laboratory

Bar Harbor, Maine, United States

Ownership: Private
Employees: ~3000
Development stage: Other

Overview

JAX provides validated preclinical mouse models and genomic tools widely used for target identification, mechanistic studies, and translational research in cancer, immunology, neurodegeneration, and complex diseases. JAX discoveries have led to breakthroughs in transplantation, stem cell therapy, and metabolic disease.[1][2][3][5]

Therapeutic areas: CardiovascularImmunologyOphthalmologyEndocrinologyNeurologyRare DiseasesOtherOncology
Modalities: Mouse modelGenetic modelStem cell therapyGene editingSmall moleculeMonoclonal antibodyCell-based studiesVaccine
Industry: Academic Hospital/University/Research

Partnerships

Johns Hopkins University (Short Course partnership)National Institutes of HealthAmerican Cancer SocietyMaine Cancer SocietyPharma/biotech companies (model and breeding services)

Beyond the preview

Go deeper on Jackson Laboratory.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jackson Laboratory.

Explore the full profile